Arich Enterprise Co Ltd

TWO:4173 Taiwan Pharmaceutical Retailers
Market Cap
$46.43 Million
NT$1.54 Billion TWD
Market Cap Rank
#23961 Global
#1443 in Taiwan
Share Price
NT$20.60
Change (1 day)
-0.24%
52-Week Range
NT$20.60 - NT$27.40
All Time High
NT$27.40
About

Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion services for prescription and instruction medications, and health consumer products; and warehousing and distribution logistics services for prescription and instruction medications, controlled drugs, cold chain products, clinical trial products, consumer health… Read more

Arich Enterprise Co Ltd (4173) - Net Assets

Latest net assets as of September 2025: NT$1.97 Billion TWD

Based on the latest financial reports, Arich Enterprise Co Ltd (4173) has net assets worth NT$1.97 Billion TWD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$5.63 Billion) and total liabilities (NT$3.66 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$1.97 Billion
% of Total Assets 35.03%
Annual Growth Rate 8.94%
5-Year Change 7.87%
10-Year Change N/A
Growth Volatility 13.89

Arich Enterprise Co Ltd - Net Assets Trend (2017–2024)

This chart illustrates how Arich Enterprise Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Arich Enterprise Co Ltd (2017–2024)

The table below shows the annual net assets of Arich Enterprise Co Ltd from 2017 to 2024.

Year Net Assets Change
2024-12-31 NT$1.92 Billion -5.02%
2023-12-31 NT$2.02 Billion +7.47%
2022-12-31 NT$1.88 Billion +3.51%
2021-12-31 NT$1.82 Billion +2.09%
2020-12-31 NT$1.78 Billion +41.02%
2019-12-31 NT$1.26 Billion +4.44%
2018-12-31 NT$1.21 Billion +14.65%
2017-12-31 NT$1.05 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Arich Enterprise Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 151.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings NT$269.29 Million 14.02%
Other Components NT$1.65 Billion 85.98%
Total Equity NT$1.92 Billion 100.00%

Arich Enterprise Co Ltd Competitors by Market Cap

The table below lists competitors of Arich Enterprise Co Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Arich Enterprise Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,022,446,000 to 1,920,852,000, a change of -101,594,000 (-5.0%).
  • Net income of 93,860,000 contributed positively to equity growth.
  • Dividend payments of 68,584,000 reduced retained earnings.
  • Other factors decreased equity by 126,870,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income NT$93.86 Million +4.89%
Dividends Paid NT$68.58 Million -3.57%
Other Changes NT$-126.87 Million -6.6%
Total Change NT$- -5.02%

Book Value vs Market Value Analysis

This analysis compares Arich Enterprise Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.80x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.96x to 0.80x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 NT$21.39 NT$20.60 x
2018-12-31 NT$24.53 NT$20.60 x
2019-12-31 NT$25.62 NT$20.60 x
2020-12-31 NT$27.19 NT$20.60 x
2021-12-31 NT$24.33 NT$20.60 x
2022-12-31 NT$25.18 NT$20.60 x
2023-12-31 NT$27.06 NT$20.60 x
2024-12-31 NT$25.76 NT$20.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Arich Enterprise Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.89%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.23%
  • • Asset Turnover: 0.18x
  • • Equity Multiplier: 3.70x
  • Recent ROE (4.89%) is above the historical average (3.39%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 0.49% 0.43% 0.23x 5.05x NT$-100.27 Million
2018 4.16% 3.86% 0.28x 3.90x NT$-70.62 Million
2019 4.80% 5.45% 0.30x 2.98x NT$-65.64 Million
2020 2.65% 3.78% 0.32x 2.22x NT$-130.82 Million
2021 3.04% 5.85% 0.21x 2.47x NT$-126.49 Million
2022 3.33% 6.15% 0.21x 2.63x NT$-125.57 Million
2023 3.78% 6.71% 0.20x 2.78x NT$-125.71 Million
2024 4.89% 7.23% 0.18x 3.70x NT$-98.23 Million

Industry Comparison

This section compares Arich Enterprise Co Ltd's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $387,121,000
  • Average return on equity (ROE) among peers: 17.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Arich Enterprise Co Ltd (4173) NT$1.97 Billion 0.49% 1.85x $27.84 Million
MedFirst Healthcare Services lnc (4175) $910.56 Million 12.40% 2.44x $32.54 Million
Great Tree Pharmacy Co Ltd (6469) $185.19 Million 18.25% 0.64x $209.14 Million
MARX Biotech Co., Ltd. (7731) $65.61 Million 21.00% 0.39x $50.74 Million